Drug Evaluation Committee The 106th Assembly of the Clinical Evaluation Committee [Part 2] New Normal Clinical Trial: Optimization and Efficiency of Clinical Trial with COVID-19 as an Opportunity
Feb 17, 2023
- Program of Part 2 (126KB)
- Keynote Speech 1-1_COVID-19 Clinical Trial Implementation and Future Issues (2.30MB)
- Keynote 1-2_COVID-19 Clinical Trials and Future Challenges (in preparation for publication)
- Keynote Speech 2_Issues of Japan's Clinical Trial Environment from the Perspective of Global Competitiveness (2.29MB)
- Keynote Speech 3_Authorities' Efforts for Innovative Drug Discovery (2.78MB)